Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 23-Apr-24 8:00 PM View:  | Ault Milton C III Director 10% Owner | Alzamend Neuro, Inc. (ALZN) | 19-Apr-24 | Private Purchase | 1,000 | $0.69 | $688.20 | < 1% 1.94M to 1.94M | |
| 03-Apr-24 5:00 PM View: | Ault Milton C III Director 10% Owner | Alzamend Neuro, Inc. (ALZN) | 01-Apr-24 | Private Purchase | 334 | $0.91 | $304.24 | < 1% 1.94M to 1.94M | |
| 25-Jan-24 5:20 PM View: | Ault Milton C III Director 10% Owner | Alzamend Neuro, Inc. (ALZN) | 23-Jan-24 | Disposition (other) | 661,168 | -- | -- | (25%) 2.6M to 1.94M | |
| 09-Jan-24 4:30 PM View: | Ault Milton C III Director 10% Owner | Alzamend Neuro, Inc. (ALZN) | 05-Jan-24 | Private Purchase | 5,000 | $1.02 | $5,092.50 | < 1% 2.59M to 2.6M | |
| 01-Apr-24 4:30 PM View: | Ault Milton C III Director 10% Owner | Alzamend Neuro, Inc. (ALZN) | 05-Jan-24 | Private Purchase | 2,000 | $1.06 | $2,127.00 | < 1% 1.94M to 1.94M | |
| 16-May-24 10:00 PM View: | McGrath Lynne Fahey Director | Alzamend Neuro, Inc. (ALZN) | 26-Dec-23 | Sale | 666 | $0.88 | $586.75 | (12%) 5.67K to 5.0K | |
| 27-Dec-23 4:30 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 26-Dec-23 | Purchase | 500 | $0.90 | $450.00 | < 1% 2.59M to 2.59M | |
| 27-Dec-23 4:30 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 22-Dec-23 | Private Purchase | 200 | $0.92 | $184.84 | < 1% 2.59M to 2.59M | |
| 26-Sep-23 6:01 PM View: | Katzoff David J Chief Financial Officer | Alzamend Neuro, Inc. (ALZN) | 26-Sep-23 | Private Purchase | 53,000 | $0.19 | $10,234.30 | 189% 28.0K to 81.0K | |
| 26-May-23 9:30 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 24-May-23 | Private Purchase | 18,000 | $0.59 | $10,704.60 | < 1% 38.87M to 38.89M | |
| 02-May-23 4:30 PM View: | Jackman Stephan Chief Executive Officer Director | Alzamend Neuro, Inc. (ALZN) | 28-Apr-23 | Private Purchase | 37,000 | $0.54 | $19,998.50 | 435% 8.5K to 45.5K | |
| 23-Mar-23 4:30 PM View: | McGrath Lynne Fahey Director | Alzamend Neuro, Inc. (ALZN) | 22-Mar-23 | Private Purchase | 10,000 | $0.44 | $4,350.00 | 13% 75.0K to 85.0K | |
| 20-Mar-23 4:30 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 17-Mar-23 | Purchase | 5,000 | $0.43 | $2,149.00 | < 1% 38.86M to 38.87M | |
| 20-Mar-23 4:30 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 16-Mar-23 | Private Purchase | 4,000 | $0.50 | $2,005.60 | < 1% 38.86M to 38.86M | |
| 28-Feb-23 4:30 PM View: | Horne William B Director | Alzamend Neuro, Inc. (ALZN) | 24-Feb-23 | Option Exercise | 500,000 | $0.00 | $2,000.00 | 100% 500.0K to 1000.0K | |
| 17-Feb-23 9:55 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 15-Feb-23 | Private Purchase | 1,000 | $0.60 | $597.30 | < 1% 38.86M to 38.86M | |
| 29-Dec-22 6:00 AM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 28-Dec-22 | Purchase | 3,100 | $0.56 | $1,744.99 | < 1% 38.85M to 38.86M | |
| 29-Dec-22 6:00 AM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 27-Dec-22 | Private Purchase | 900 | $0.59 | $531.90 | < 1% 38.85M to 38.85M | |
| 23-Dec-22 4:30 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 21-Dec-22 | Private Purchase | 5,000 | $0.81 | $4,049.50 | < 1% 38.85M to 38.85M | |
| 20-Dec-22 4:30 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 19-Dec-22 | Purchase | 23,000 | $0.82 | $18,813.20 | < 1% 38.83M to 38.85M | |
| 20-Dec-22 4:30 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 16-Dec-22 | Private Purchase | 20,000 | $0.90 | $17,960.00 | < 1% 38.81M to 38.83M | |
| 21-Nov-22 4:30 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 18-Nov-22 | Private Purchase | 1,000 | $1.29 | $1,289.00 | < 1% 38.8M to 38.81M | |
| 15-Nov-22 4:30 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 11-Nov-22 | Acquisition (other) | 933,334 | $1.50 | $1,400,000.00 | 2% 37.87M to 38.8M | |
| 03-Nov-22 4:30 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 02-Nov-22 | Private Purchase | 1,000 | $1.13 | $1,129.90 | < 1% 37.87M to 37.87M | |
| 01-Nov-22 10:00 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 31-Oct-22 | Private Purchase | 6,000 | $1.19 | $7,135.80 | < 1% 37.86M to 37.87M | |
| 14-Oct-22 4:30 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 12-Oct-22 | Private Purchase | 2,000 | $1.23 | $2,466.80 | < 1% 37.86M to 37.86M | |
| 07-Oct-22 4:30 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 06-Oct-22 | Private Purchase | 1,000 | $1.43 | $1,429.30 | < 1% 37.86M to 37.86M | |
| 30-Sep-22 4:30 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 29-Sep-22 | Private Purchase | 3,500 | $1.19 | $4,152.75 | < 1% 37.86M to 37.86M | |
| 26-Sep-22 6:45 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 23-Sep-22 | Acquisition (other) | 73,500 | $0.94 | $69,457.50 | < 1% 37.78M to 37.86M | |
| 20-Sep-22 4:30 PM View: | Jackman Stephan Chief Executive Officer Director | Alzamend Neuro, Inc. (ALZN) | 19-Sep-22 | Private Purchase | 8,500 | $1.23 | $10,414.20 | 100% 0 to 8.5K | |
| 14-Sep-22 5:07 PM View: | Katzoff David J Chief Financial Officer | Alzamend Neuro, Inc. (ALZN) | 14-Sep-22 | Private Purchase | 10,000 | $1.11 | $11,092.00 | 56% 18.0K to 28.0K | |
| 29-Aug-22 4:30 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 26-Aug-22 | Private Purchase | 9,100 | $0.94 | $8,561.28 | < 1% 37.78M to 37.78M | |
| 26-Aug-22 4:30 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 25-Aug-22 | Private Purchase | 4,900 | $0.96 | $4,703.51 | < 1% 37.77M to 37.78M | |
| 23-Aug-22 4:30 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 22-Aug-22 | Private Purchase | 36,000 | $0.97 | $34,894.80 | < 1% 37.73M to 37.77M | |
| 18-Aug-22 4:30 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 16-Aug-22 | Private Purchase | 15,000 | $1.08 | $16,213.50 | < 1% 37.72M to 37.73M | |
| 16-Aug-22 4:52 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 15-Aug-22 | Private Purchase | 14,000 | $1.06 | $14,833.00 | < 1% 37.71M to 37.72M | |
| 15-Aug-22 5:04 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 12-Aug-22 | Private Purchase | 1,000 | $1.04 | $1,040.00 | < 1% 37.7M to 37.71M | |
| 04-Aug-22 4:30 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 03-Aug-22 | Private Purchase | 2,000 | $0.95 | $1,895.60 | < 1% 37.7M to 37.7M | |
| 28-Jul-22 5:48 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 27-Jul-22 | Private Purchase | 5,700 | $0.87 | $4,959.00 | < 1% 37.7M to 37.7M | |
| 25-Jul-22 4:30 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 22-Jul-22 | Private Purchase | 2,300 | $0.91 | $2,081.73 | < 1% 37.69M to 37.7M | |
| 19-Jul-22 4:30 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 18-Jul-22 | Private Purchase | 10,000 | $0.98 | $9,773.00 | < 1% 37.68M to 37.69M | |
| 30-Jun-22 5:00 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 29-Jun-22 | Private Purchase | 10,000 | $0.88 | $8,830.00 | < 1% 37.67M to 37.68M | |
| 21-Jun-22 6:16 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 17-Jun-22 | Private Purchase | 10,000 | $0.88 | $8,841.00 | < 1% 37.66M to 37.67M | |
| 16-Jun-22 6:39 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 15-Jun-22 | Private Purchase | 10,000 | $0.87 | $8,740.00 | < 1% 37.71M to 37.72M | |
| 15-Jun-22 5:00 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 14-Jun-22 | Private Purchase | 10,000 | $0.85 | $8,474.00 | < 1% 37.7M to 37.71M | |
| 09-Jun-22 4:30 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 08-Jun-22 | Private Purchase | 8,000 | $0.95 | $7,576.00 | < 1% 37.69M to 37.7M | |
| 08-Jun-22 4:30 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 07-Jun-22 | Private Purchase | 2,000 | $0.94 | $1,881.40 | < 1% 37.69M to 37.69M | |
| 03-Jun-22 5:36 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 02-Jun-22 | Private Purchase | 8,000 | $0.96 | $7,679.20 | < 1% 37.68M to 37.69M | |
| 31-May-22 5:00 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 27-May-22 | Purchase | 12,000 | $0.96 | $11,506.80 | < 1% 37.61M to 37.63M | |
| 31-May-22 5:00 PM View: | Ault Milton C III 10% Owner | Alzamend Neuro, Inc. (ALZN) | 26-May-22 | Private Purchase | 10,000 | $0.91 | $9,120.00 | < 1% 37.6M to 37.61M |
